Evaluation of effect of hybrid bioartificial liver using end-stage liver disease model

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

216

HTML

1500

Figures (1-1)

139

Tables (1-3)

122

Sum=1977

May 1, 2004 (publication date) through Jun 15, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. May 1, 2004; 10(9): 1379-1381
Published online May 1, 2004. doi: 10.3748/wjg.v10.i9.1379

Table 1 General data of patients

No	Sex	Age(yr)	Diagnosis	Multi-organs failure	Outcome
1	Female	43	ALF, HBV	Liver, brain	Spontaneous recovery
2	Male	31	SALF, HBV	Liver, brain	Recovery spontaneous
3	Male	33	SALF, HBV and alcoholic liver disease	Liver, coagulopathy, cardiovascular	Orthotopic liver transplantation
4	Female	27	ALF, drug induced liver injury	Liver, brain	Death
5	Male	31	ALF, HBV	Liver, kidney	Death

ALF: Acute liver failure; SALF: Sub-acute liver failure; HBV: Hepatitis B virus.

Citation: Liu Q, Duan ZP, Huang C, Zhao CH. Evaluation of effect of hybrid bioartificial liver using end-stage liver disease model. World J Gastroenterol 2004; 10(9): 1379-1381
URL: https://www.wjgnet.com/1007-9327/full/v10/i9/1379.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i9.1379